All Articles

A new global partnership sees tech giant UST back Halo's platform. Can their combined might challenge market leaders and deliver on the promise of faster ROI?

BioMendics secured a key FDA Fast Track designation for its EBS therapy, a strategic move that de-risks development and signals a new era for rare disease treatment.

From tackling healthcare shortages in Kentucky to empowering neurodivergent students in PA, immersive tech is finally delivering measurable results. But can it scale?

A real estate firm's massive investment in a Scottish battery project signals a new frontier for investors: turning land into a linchpin for the green grid.

Litify's new platform, powered by Supio, promises to automate up to 50% of pre-litigation work. Is this the dawn of the AI-executed legal workflow?

Xurrent's new built-in iPaaS challenges ITSM norms by letting AI agents act, not just advise, aiming to finally close the stubborn enterprise AI ROI gap.

Following a major acquisition, Revolution BTS emerges as a new force in urban mobility, launching advanced bikes to improve city life and challenge the market.

As Canada faces a monumental energy shift, Toronto Hydro CEO Jana Mosley takes the helm at Electricity Canada, tasked with guiding the nation’s grid modernization.

With a fresh $50M from a top tech investor, Partly is bringing its purpose-built AI to the US, aiming to overhaul the analog chaos of auto parts.

As WordCamp US 2026 heads to Phoenix, the platform powering 40% of the web focuses on AI, community, and the strategies defining digital commerce.

As CoreHealth appoints its COO to the top job, it signals a deliberate shift: doubling down on a tech-first, systemic approach to corporate wellness.

Points of Light's annual list is more than a ranking. It's a data-driven look at how top firms are embedding social impact into their core for a dual ROI.

A new partnership is turning passive stormwater drains into predictive, intelligent networks. This isn't just about preventing floods—it's a new blueprint for urban resilience.

A developer's bankruptcy puts new, fully-leased retail and office assets on the block. Here's why savvy investors see a rare opportunity in Morgantown.

With a fresh $190M, Osanni Bio is pioneering a radical new model for drug discovery—building an ecosystem of specialized spinoffs to accelerate cures.

An influential OB-GYN is challenging the medical establishment to view menopause not as a niche issue, but as a core aging science, backing her call with a new foundation.

Hospitals are deploying AI weapons detection to protect staff from rising violence. It's working, but this new security brings complex questions of privacy and equity.

LGI Homes opens Chima Ranch in Yuba City, promising modern living. But beyond the hype, we explore the real cost, the strategic ADU play, and the brand's mixed reputation.

Amid crushing industry pressures, McKesson's ideaShare event reveals a strategic blueprint: leveraging AI and advocacy to keep independent pharmacies alive.

The ELC appoints Crystal L. Brown, a proven leader from National Geographic and Howard University, to steer its narrative in a pivotal moment for DEI.